Unique expression of HRF20 (CD59) in human nervous tissue

Microbiol Immunol. 1997;41(4):321-9. doi: 10.1111/j.1348-0421.1997.tb01208.x.

Abstract

Damage to autologous tissue by complement is limited by several widely distributed membrane-associated glycoproteins which restrict the action of the complement in homologous species. These include decay accelerating factor (DAF), membrane cofactor protein (MCP) and 20 kDa homologous restriction factor (HRF20,CD59). Using immunohistochemical techniques, we examined the localization of these proteins in the central nervous system (CNS) and peripheral nervous system (PNS) using non-neurological human nervous tissue since some complement components have been demonstrated to be synthesized in the CNS. There was no evidence of parenchymal staining by anti-DAF or anti-MCP antibodies in either type of tissue except for the staining of the endothelium in capillaries. On the other hand, anti-HRF20 antibody clearly stained myelinated axons in the CNS as well as Schwann cells in the PNS. In addition, we detected positive staining by anti-DAF antibody in the PNS of a Paroxysmal nocturnal hemoglobinuria (PNH) patient who is genetically deficient in HRF20.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 2-Methyl-4-chlorophenoxyacetic Acid / immunology
  • 2-Methyl-4-chlorophenoxyacetic Acid / metabolism
  • Aged
  • Axons / metabolism
  • Brain / metabolism*
  • CD55 Antigens / immunology
  • CD55 Antigens / metabolism
  • CD59 Antigens / immunology
  • CD59 Antigens / metabolism*
  • Capillaries / metabolism
  • Endothelium / blood supply
  • Female
  • Hemoglobinuria, Paroxysmal / metabolism
  • Humans
  • Immunohistochemistry
  • Male
  • Peripheral Nerves / metabolism*
  • Schwann Cells / metabolism

Substances

  • CD55 Antigens
  • CD59 Antigens
  • 2-Methyl-4-chlorophenoxyacetic Acid